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Abstract: Background: Left ventricular hypertrophy (LVH), traditionally considered an adaptive
mechanism that is aimed at the maintenance of LV systolic function, is absent in 10%–35% of
patients with severe aortic stenosis (AS). Our aim was to estimate the clinical and hemodynamic
characteristics in patients with severe AS and absent LVH, or inadequately low LV mass (i-lowLVM)
relative to an individual hemodynamic load. Methods: We retrospectively analyzed in-hospital
records of 100 patients with pure severe degenerative AS, preserved LV systolic function and
without relevant coexistent diseases, except for well-controlled hypertension or diabetes. Results:
Clinical characteristics were similar in patients with and without LVH, as well as those with and
without i-lowLVM, except for slightly lower GFR at i-lowLVM. When compared to their counterparts,
subjects without LVH or with i-lowLVM had smaller LV cavities, decreased LV wall thicknesses
and higher EF. There were no significant differences in stenosis severity and indices of afterload
(valvulo-arterial impedance and circumferential end-systolic LV wall stress), according to the presence
or absence of either LVH or i-lowLVM. However, LV fractional shortening at the midwall level was
elevated only in patients with i-lowLVM, but not in those without LVH, compared to the remainder
(15.8 ± 3.3 vs. 12.9 ± 3.2%, p < 0.001 for those with and without i-lowLVM, respectively; 13.7 ± 3.7
vs. 13.8 ± 3.6% for LVH presence and absence, p = 0.9). Conclusions: Inadequately low LVM relative
to the individual hemodynamic load could potentially reflect a different mode of the LV response
to severe AS, associated with enhanced load-independent LV systolic performance, i.e., better LV
contractility. If confirmed in a large series of patients, our small preliminary study may add to the
possible mechanisms of a previously reported counterintuitive tendency of a lower, not higher, risk of
adverse outcome in patients with low LV mass despite severe AS. Prospective studies are warranted,
in order to determine a potential utility of LVM inadequacy in the risk stratification of patients
with AS.
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1. Introduction
Left ventricular hypertrophy (LVH), traditionally considered an adaptive mechanism that is
aimed at the maintenance of LV systolic function, is absent in 10%−35% of patients with severe aortic
stenosis (AS) [1–4], the second common cause of LV pressure overload. Additionally, a classical
paradigm of a net benefit from LVH has been challenged by clinical and experimental data [5–12].
Importantly, the presence and magnitude of LVH is a well-recognized independent predictor of adverse
cardiovascular (CV) outcome, including death and developing heart failure (HF), in population-based
cohorts, hypertension, and AS [6–12]. This is compatible with reports of no excessive mortality [4],
or even better early postoperative survival [2] and lower risk of adverse CV events [3] in patients with
severe AS and absent LVH.
Moreover, patients with inadequately low LV mass (i-lowLVM), i.e., observed LV mass (LVM)
in the lower part of the distribution of the value predicted from an individual hemodynamic load,
had either a similar [13] or lower [3] risk of adverse CV events than their counterparts with an
appropriate LVM in hypertension [13] and severe AS [3].
Notably, only a few studies have been focused on characteristics of patients with low LVM,
despite severe AS [1–4]. Therefore, our aim was to estimate the clinical and hemodynamic
characteristics in patients with severe AS and absent LVH or i-lowLVM.
2. Materials and Methods
2.1. Patients
We retrospectively analyzed in-hospital records of patients with pure severe degenerative AS (aortic
valve area index [AVAI] <0.6 cm2/m2 or mean transvalvular pressure gradient >40 mmHg) without
relevant coexistent diseases, except for well-controlled diabetes or hypertension, with preserved LV
ejection fraction (≥50%) [14]. A complete list of exclusion criteria, including clinical or angiographic
evidence of significant coronary artery disease (CAD) and estimated glomerular filtration rate
(GFR) below 30 mL/min per 1.73 m2 (by the CKD-EPI formula), was reported earlier in detail [15].
Besides patients with severe AS out of the previously described AS subjects with moderate-to-severe
AS [15], additional patients were also included into the final analysis (Bioethical Committee of
Jagiellonian University, approval No. 122.6120.228.2016), provided that they fulfilled the inclusion and
exclusion criteria.
2.2. Data Analysis
From routinely recorded parameters of LV structure and function, we calculated LV fractional
shortening at the midwall level (mwFS), assuming a constant volume of the inner myocardial “shell”
between the LV midwall and the endocardium, according to a simplified spherical LV model [16,17].
Additionally, estimated circumferential end-systolic LV wall stress (cESS) and valvulo-arterial
impedance (Zva), indices of LV afterload, were computed. cESS was calculated from LV internal
diameter and wall thickness at end-systole, averaged-in hospital systolic blood pressure (SBP),
and maximal transvalvular aortic pressure gradient (APGmax) [16,18–20], while Zva was derived
from the SBP, mean transvalvular aortic pressure gradient, and stroke volume index [21]. Then,
we computed a difference between the measured LVM (by the modified Devereux equation [22]) and
that predicted from the height, gender, and an individual’s hemodynamic load (computed from a
product of stroke volume and the sum of SBP and APGmax) by a previously validated formula [20,23,24].
Accordingly, LVMmeasured (g) = 0.8 × (1.04 × (((LVd + IVSd + PWd)3 − LVd3))) + 0.6, where LVd is
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the LV internal diameter, IVSd is the interventricular septum thickness, and PWSd is the posterior
wall thickness (all measurements in end-diastole from the parasternal approach and expressed in
cm) [22], while LVpredicted (g) = 55.37 + (0.009216 × (stroke volume (mL)) × (SBP + APGmax (mmHg)))
+ (6.63 × (height (m))2.7) − (18.1 − n), with n = 1 for men and n = 2 for women [3,17,20,23,24].
The difference between the measured and predicted LVM was termed an excess of LVM (eLVM),
and expressed as a percentage of the predicted LVM, assumed to be 100%: eLVM = ((LVMmeasured −
LVMpredicted)/LVMpredicted) × 100% [17]. Because LVH, defined according to the classical mass criteria
(i.e., LVMmeasured >95 g/m2 for women and >115 g/m2 for men), was absent in 23% of our patients,
for consistency, we assumed i-lowLVM as an eLVM below the 23th percentile of its distribution (i.e.,
eLVM <13%) in the study population. In addition to the indexation of LVM for body-surface area,
we also repeated the analysis after the LVM normalization for height to the power of 2.7, as previously
proposed [3,13,20].
2.3. Statistical Analysis
Data are shown as means and SD, or medians and interquartile range, and numbers with
percentages. The analyzed subjects were compared according to the LVH presence or the LVM
inadequacy by a 2-tailed Student’s t-test or the Mann–Whitney U-test, and Fisher’s test for continuous
and categorical data, respectively. A Bonferroni-corrected p-value <0.05 was inferred significant,
which corresponds to a pre-adjusted p-value <0.002.
3. Results
Clinical characteristics were similar in patients with and without LVH by the classical mass
criteria, as well as with and without i-lowLVM relative to the individual hemodynamic load, except
for slightly lower GFR in those with i-lowLVM (Table 1).
Table 1. Demographic and clinical characteristics according to LVH absence or LVM inadequacy.
Characteristic
LV Hypertrophy
(LVH)
Inadequately Low LVM
(i-lowLVM)
No
n = 23
Yes
n = 77 p
Yes
n = 23
No
n = 77 p
Age, years 69 ± 8 70 ± 10 NS 72 ± 6 69 ± 11 NS
Men/women, n (%) 14 (61%) 34 (44%) NS 13 (56%) 35 (45%) NS
BSA, m2 1.9 ± 0.1 1.8 ± 0.2 NS 1.9 ± 0.1 1.8 ± 0.2 NS
BMI, kg/m2 30.4 ± 4.4 29.0 ± 4.6 NS 29.3 ± 4.4 29.5 ± 4.6 NS
Hypertension, n (%) 20 (87%) 64 (83%) NS 21 (91%) 63 (82%) NS
Diabetes, n (%) 7 (30%) 22 (29%) NS 9 (39%) 20 (26%) NS
GFR, mL/min/1.73 m2 70 ± 16 77 ± 19 0.09 67 ± 15 78 ± 20 0.02
Symptoms, n (%) 14 (61%) 37 (48%) NS 15 (65%) 36 (47%) NS
Mean BP, mm Hg 95 ± 11 92 ± 9 NS 94 ± 11 92 ± 9 NS
Medications, n (%)
ACEI or ARB 7 (30%) 20 (26%) NS 9 (39%) 18 (23%) NS
Beta-blocker 13 (57%) 44 (57%) NS 15 (65%) 42 (55%) NS
Diuretics 12 (52%) 36 (47%) NS 15 (65%) 33 (43%) 0.07
Data are shown as mean ± standard deviation or numbers (percentages). ACEI: angiotensin-converting enzyme
inhibitor; ARB: angiotensin receptor blocker; BMI: body mass index; BP: blood pressure; BSA: body surface area;
GFR: estimated glomerular filtration rate; n: number; NS: non-significant.
When compared to their counterparts, subjects without LVH or with i-lowLVM had smaller LV
cavities, decreased LV wall thicknesses, and higher EF (Table 2). There were no significant differences
in AVAI or in indices of afterload (cESS and Zva), according to the presence or absence of either LVH
or i-lowLVM. However, mwFS was elevated only in patients with i-lowLVM, but not in those without
LVH, in comparison to the remainder (Table 2).
The results were virtually unchanged when the LVH definition was based on the indexation of
LVM for height instead of for body surface area.
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Table 2. Echocardiographic characteristics and LV afterload according to the presence of LVH or
LVM inadequacy.
Characteristic
LV Hypertrophy
(LVH)
Inadequately Low LVM
(i-lowLVM)
No
n = 23
Yes
n = 77 p
Yes
n = 23
No
n = 77 p
AVAI, cm2/m2 0.5 ± 0.1 0.4 ± 0.1 NS 0.5 ± 0.1 0.4 ± 0.1 NS
LVd, cm 4.4 ± 0.4 5.0 ± 0.7 <0.001 4.6 ± 0.6 5.0 ± 0.8 0.03
PWd, cm 1.1 ± 0.1 1.3 ± 0.2 <0.001 1.0 ± 0.1 1.3 ± 0.2 <0.001
IVSd, cm 1.1 ± 0.2 1.5 ± 0.3 <0.001 1.1 ± 0.2 1.5 ± 0.3 <0.001
RWT 0.50 ± 0.07 0.57 ± 0.16 0.07 0.47 ± 0.06 0.58 ± 0.15 0.001
EF, % 63 ± 11 58 ± 7 0.004 64 ± 10 57 ± 7 <0.001
mwFS, % 13.8 ± 3.6 13.7 ± 3.7 NS 15.8 ± 3.3 12.9 ± 3.2 <0.001
cESS, hPa 201 ± 81 178 ± 92 NS 188 ± 72 181 ± 97 NS
Zva, mmHg / mL/m2 6.0 ± 1.5 5.4 ± 1.9 NS 5.5 ± 1.2 5.4 ± 2.0 NS
eLVM, % 8 [−2,24] 56 [26,81] <0.001 5 [−6,9] 57 [29,81] <0.001
Data are shown as mean ± standard deviation or median ± interquartile range. Significant Bonferroni-corrected
p-values are marked in bold. AVAI: aortic valve area index; cESS: circumferential end-systolic LV wall stress;
EF: ejection fraction; eLVM: excess of LV mass; IVSd: interventricular septum thickness at end-diastole; LV: left
ventricular; LVd: LV end-diastolic diameter; LVM: LV mass; mwFS: LV midwall fractional shortening; n: number;
NS: non-significant; PWd: posterior wall thickness at end-diastole; RWT: relative LV wall thickness; Zva:
valvulo-arterial impedance.
4. Discussion
Our salient observation was an association of LVM inadequacy, but not LVH absence, with better
LV systolic performance at the midwall level in severe AS. In addition, cESS and Zva—indices of
afterload—were similar, while LV diastolic diameter, a raw measure of preload, was lower in AS
patients with i-lowLVM than in their counterparts. Accordingly, this constellation of findings suggests
that a load-independent increase in LV function, i.e., improved LV contractility, may be specific for AS
subjects with i-lowLVM, and not for those with absent LVH.
Patients without LVH had smaller LV cavity sizes and thinner LV walls, as well as higher EF when
compared to those with LVH, in agreement with previous reports [1,2,4]. Barasch et al. [4] speculated
that some mechanisms could offset the detrimental effects of afterload excess in patients with severe
AS and absent LVH, thereby explaining a tendency for better CV outcomes in that subset of AS subjects.
Nevertheless, in our hands, cESS appeared to be unchanged in patients without LVH, which was
secondary to LV concentric remodeling in the majority of this subgroup (as in earlier reports [1,2]),
thus keeping cESS relatively constant. In addition, mwFS was also similar in patients with and without
LVH. This indicates that, despite the absence of LVH, LV afterload and myocardial systolic function are
preserved, while a higher EF in AS patients free of LVH seems rather to be a consequence of concentric
LV geometry and better LV chamber function, not improved myocardial performance.
In contrast, patients with i-lowLVM exhibited increased both EF and mwFS in comparison to their
counterparts, with a ratio of measured to predicted LVM above the 23th percentile of its distribution
in the study population. This appears to be partially analogous to an early report by De Simone et
al. [13] who described a higher cESS-corrected mwFS in hypertensive patients with low LVM, defined
as an eLVM below −32% (corresponding to the 2.5th percentile of eLVM distribution in a reference
population) despite similar LV end-diastolic diameter, a raw index of preload. That observation [13]
was indicative of better LV contractility, as in our patients with i-lowLVM, who exhibited increased
mwFS, unchanged cESS, and even smaller LV diameter, compared to the remainder. Of note, in those
hypertensive subjects with low LVM, mean RWT was as low as 0.28 [13], while in our AS subjects with
i-lowLVM, RWT averaged 0.47, reflecting concentric LV remodeling in most of them. As cESS was not
elevated in AS patients with i-lowLVM, it may be concluded that—unlike in hypertension—concentric
remodeling appears to be necessary to preserve normal cESS in the majority of patients with severe AS
and i-lowLVM. With regard to a potential mechanism of this observation, it can be speculated that
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severe AS results in a fixed and probably more potent LV pressure overload, in contrast to hypertension,
frequently associated with fluctuating blood pressure.
Notably, excessive LVH, i.e., inappropriately high LVM out of proportion to LV afterload, is
associated with depressed mwFS, despite a lower or unchanged cESS, indicating depressed LV
myocardial performance in patients with mild-to-severe AS [3,19,20], which has also recently been
confirmed by our group in moderate AS [17]. Therefore, our results could reflect a continuum of the
relationship between LV contractility, wall stress, and LVH adequacy, in agreement with a concept that
was previously proposed by Aurigemma et al. [18,25], De Simone et al. [13], and Palmieri et al. [26]
for hypertension, and later by Mureddu et al. [19] and Cioffi et al. [3,20] for AS. On the basis of
LV stress-shortening relations, they suggested that excessive LVH may be a compensatory, albeit
largely ineffective compensatory mechanism triggered by primary myocardial dysfunction, and
aimed at restoring LV systolic performance through lowering LV wall stress. Consequently, this
mechanism would not be operational in subjects with enhanced LV contractility, thereby contributing
to the association of apparently low LVM with increased cESS-corrected mwFS in patients with
hypertension [13]. Hence, our report is the first to demonstrate a similar mechanism in AS, another
common cause of LV pressure overload.
The enhanced LV contractile function might be protective against LV dysfunction in severe AS
with i-lowLVM. In accordance with this hypothesis, Kupari et al. [2] observed an increased EF, a 3-fold
lower prevalence of HF, and a better 3-month postoperative outcome in patients with a lack of LVH,
despite critical AS. Additionally, in an early report, Seiler and Jenni [1] described a better ergometric
working capacity in AS patients with severe AS and no LVH. Unfortunately, the cited authors [1,2]
estimated only the LVH presence, and not the LVM adequacy, which limits more detailed comparisons
with the present study. Nonetheless, apart from this limitation, the proposed hypothesis can explain
a lower risk of adverse CV events (whose majority consisted of aortic valve replacement and HF
hospitalizations) in patients with severe AS in the lower tertile of the measured-to-predicted LVM
ratio (<108%, i.e., eLVM <8%) [3], close to the cut-off value for i-lowLVM assumed in the present study
(eLVM <13%). Consequently, LVM “inadequacy” can represent not a lack of putatively “compensatory”
LVH, but rather, a different mode of LV response to pressure overload, as proposed by Kupari et al. [2]
on the basis of an absence of LVM regression after aortic valve replacement in patients without LVH.
Due to a paucity of studies, determinants of absent LVH and especially i-lowLVM still remain
unexplored. In agreement with earlier observations [1,2], the percentage of men in AS subjects without
LVH was insignificantly higher than in those with LVH. A similar, albeit weaker, tendency was
observed in AS patients with i-lowLVM. To the best of our knowledge, sex-dependent differences
in the prevalence of i-lowLVM in severe AS have not been reported so far [3]. However, as a higher
proportion of men had been described in AS with inappropriately high LVM versus appropriate
LVM [3,20], it may be suggested that the adequacy of the LV hypertrophic response to chronic LV
overload in AS appears to be modulated by gender.
Limitations
First, a retrospective design and a relatively low number of patients are major limitations of our
report. However, exclusively subjects without coexistent diseases, including CAD, were entered into
the final analysis, in order to reduce the heterogeneity of the study group. Second, the individual
hemodynamic load was estimated on the basis of in-hospital BP recordings and echocardiography,
while averaged values over a long period of time would be more appropriate. Nevertheless,
we analyzed only patients with well-controlled hypertension and stable BP, which suggests that
the computed parameters could be, to some degree, representative for a given subject. Third, medical
therapy, which is known to affect LVM, was not uniform. However, the proportions of patients treated
with renin–angiotensin system inhibitors, drugs with a well-recognized ability to attenuate LVH, were
similar, according to LVH presence or LVM inadequacy.
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5. Conclusions
Keeping in mind the limitations of our small retrospective study, inadequately low LVM relative
to the individual hemodynamic load could potentially reflect a different mode of LV adaptation to
AS, associated with enhanced load-independent LV systolic performance, i.e., better LV contractility.
If confirmed in a large series of patients, our preliminary report might add to the possible mechanisms
of a previously reported counterintuitive tendency of a lower, not higher, risk of adverse outcome in
patients with low LV mass, despite severe AS. Prospective studies are warranted in order to determine
a potential utility of LVM inadequacy for the prediction of clinical outcomes and risk stratification of
patients with AS.
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